Curiox Biosystems nets $15m Series C

Curiox Biosystems Inc, a provider of biological sample preparation automation solutions, has secured $15 million in Series C financing.

17 March 2022•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles